Feature | September 11, 2013

Large Randomized Trial: Lucas Chest Compression System Effective, Reliable in Pre-hospital Cardiac Arrest

Results from the LINC (Licas in Cardiac Arrest) trial shows good outcomes in both Lucas CPR and manual CPR groups

LINC Study Resuscitation Devices Defibrillator CPR Lucas Chest Compression

September 11, 2013 — The main results of the large randomized LINC study, which compared the effectiveness of the Lucas mechanical chest compression system to high quality manual chest compressions, were presented at the European Society of Cardiology Congress in Amsterdam, the Netherlands. The LINC study showed similar short-term survival rates for Lucas (23.6%) and manual (23.7%) chest compressions. At six-months, 8.5% of the patients treated with LUCAS were alive with good neurological outcomes compared to 7.6% in the manual group.

The study provides the highest level of evidence that sudden cardiac arrest patients can be effectively treated using Lucas mechanical chest compressions. The Lucas chest compression system provides several additional benefits to resuscitation care:

  • Frees rescuers to provide other life-saving therapies without the limitations or difficulties of manual cardiopulmonary resuscitation (CPR)
  • Standardizes the quality of chest compressions adhering to the European Resuscitation Council and American Heart Assn. Guidelines for CPR depth, rate and recoil
  • Allows for effective CPR during patient transportation, while improving rescuer safety
  • Can be used in the catheterization laboratory to reopen blocked arteries during CPR

The LINC study led and presented by Professor Sten Rubertsson M.D., Ph.D., from Uppsala University, Uppsala, Sweden, included 2,589 out-of-hospital cardiac arrest patients in Europe over five years, from 2008 to 2013. It is one of the largest controlled, envelope-randomized trials for out-of-hospital cardiac arrest in history. The patients were randomized to either the Lucas device receiving mechanical chest compressions with defibrillation provided during ongoing compressions, or to manual chest compressions according to the European Resuscitation Council and American Heart Assn. Guidelines for CPR.

"The results are encouraging, with the vast majority of survivors having good neurological status at six months — 99 percent in the Lucas group, 94 percent in the manual group." said Rubertsson. "Moreover, the overall survival rate is high considering the study excluded the most viable groups; the patients defibrillated before EMS arrival and EMS witnessed cardiac arrests that were successfully defibrillated with the first shock."

The LINC study included sudden cardiac arrest patients in six European centers; Uppsala, Gävle, Västerås and Malmö in Sweden, Utrecht in the Netherlands, and Dorset in the United Kingdom. Over 770 paramedics at 26 ambulance stations and 1,500 in-hospital employees at 14 hospitals took part in the LINC trial. The study was initiated, designed and partly funded by Uppsala University, sponsored by Physio-Control Inc., coordinated independently by Uppsala Clinical Research Center, Uppsala, Sweden, and conducted in accordance to clinical and ethical principles.

For more information: www.physio-control.com

Related Content

wearable defibrillators prevent sudden cardiac death in pediatric patients
Feature | Sudden Cardiac Arrest| May 11, 2017
May 11, 2017 — A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in
Physio-Control Launches HeartSine samaritan PAD 360P Automated External Defibrillator in United States
Technology | Defibrillator Monitors| April 24, 2017
Physio-Control announced April 19 that the company’s HeartSine samaritan PAD 360P (SAM 360P) fully automatic external...
AEDs, automated external defibrillators, requirements, U.S. schools, JACC study
News | Defibrillator Monitors| March 30, 2017
Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed...
Philips, FDA, class I recall, HeartStart MRx Monitor/Defibrillator
News | Defibrillator Monitors| March 28, 2017
Philips and the U.S. Food and Drug Administration (FDA) announced the company has initiated a recall of its HeartStart...
Zoll, Hospital Wearable Defibrillator, HWD, FDA premarket approval
Technology | Defibrillator Monitors| March 10, 2017
Zoll Medical Corp. announced that the company’s Hospital Wearable Defibrillator (HWD) has been granted premarket...
LifePak, AED, sudden cardiac arrest, defibrillator, automatic external defibrillator

A Physio-Control LifePak CR Plus defibrillator shown in use during a hand-off to paramedics, who use larger, more sophisticated defibrillator-monitors (behind gloved paramedic).

Feature | Sudden Cardiac Arrest| September 28, 2016 | Allied Market Research
Automated external defibrillators (AED) are portable and lightweight devices used to deliver an electric shock throug
sudden cardiac arrest, out-of-hospital, comatose patients, University of Arizona study, wake up
News | Sudden Cardiac Arrest| July 13, 2016
Physicians may be drawing conclusions too soon about survival outcomes of patients who suffered a cardiac arrest...
Zoll LifeVest wearable defibrillator, WEARIT-II Registry results, CardioStim EuroPace 2016
News | Defibrillator Monitors| June 21, 2016
Zoll Medical Corp. announced that patients experience a high one-year survival rate following use of the LifeVest...
ResQCPR System, resuscitation devices, cardiac arrest, CPR, FDA
Technology | March 09, 2015
The U.S. Food and Drug Administration (FDA) approved the ResQCPR System, a system of two devices for first responders...
Overlay Init